Evidence for a role of the arachidonic acid cascade in affective disorders: a review (Q35684403)

9 August 2017

1 reference

title

Evidence for a role of the arachidonic acid cascade in affective disorders: a review (English)

1 reference

9 August 2017

M Elizabeth Sublette

1

1 reference

9 August 2017

Mark J Russ

series ordinal

2

1 reference

9 August 2017

Gwenn S Smith

series ordinal

3

1 reference

9 August 2017

publication date

1 April 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

95-105

1 reference

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Phospholipase A2 and G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

The catecholamine hypothesis of affective disorders: a review of supporting evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

The immune system, depression and the action of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Prostaglandin D2 and sleep regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Are cytokines associated with neuropsychiatric syndromes in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Lowering of brain levels of the depressant prostaglandin D2 by the anti-depressant tranylcypromine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Effects of biogenic amines and psychotropic drugs on endogenous prostaglandin biosynthesis in the rat brain homogenates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Polyunsaturated fatty acid deficit in patients with bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Tolmetin induction of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Lithium decreases turnover of arachidonate in several brain phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Chronic lithium treatment decreases brain phospholipase A2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Lithium chloride, administered chronically to rats, does not affect the fractional phosphorylation of brain cytosolic phospholipase A2, while reducing its net protein level

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Effect of valproate on lipogenesis in neonatal rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Adaptation of postimplantation embryos to culture: Membrane lipid synthesis and response to valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Incorporation of [3H]valproic acid into lipids in GT1-7 neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Lack of seasonal mood change in the Icelandic population: results of a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Eicosapentaenoic acid in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Therapeutic aspects of cannabis and cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Neuroimaging in bipolar disorder: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Changes in the 31P-NMR spectra of cats receiving lithium chloride systemically

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Brain incorporation of [1-11C]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1399-5618.2003.00094.X

10.1046/J.1399-5618.2003.00094.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference